TrialInternational journal of nanomedicine2021

Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.

Zaki F Aref et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.